Non small cell - Globe Thesis

Keyword [Non small cell] Result: 161 - 180 \| Page: 9 of 10
161.	Initial Partial Response And Stable Disease Indicate Similar Progression-free Survival For Chemotherapeutical Patients With Advanced Non-small Cell Lung Cancer
162.	Expression Of 14-3-3zeta And Its Influence On Tumor Development And Apoptosis In Stage T₁ Non-small Cell Lung Cancer
163.	Expression And Clinical Significance Of Survivin,P53 And Bcl-2 In ⅢA Non-small Cell Lung Cancer(NSCLC)before And After Neoadjuvant Chemotherapy
164.	The Mechanism Of Gefitinib Resistance Induced By Hepatocyte Growth Factor In Sensitive Non-small Lung Cancer Cells
165.	Hepatocellular Careinoma HepG2 Therapy Mediated By Tumor Suppressor Of Non-small Cell Lung Cancer 1
166.	Effect Of NKTm Cells Plus Cisplatin/cetuximab Treatment On NSCLC Cells In Vitro
167.	Concurrent Chemoradiotherapy For Locally Advanced Non-small Cell Lung Cancer Clinical Outcomes Of Patients With Malignant Lung Lesions Treated With Stereotactic Body Radiation Therapy
168.	Expression Of Nm23 And E-cadherin In Stage Ⅰ Non-small Cell Lung Cancer, And Their Relationship With Lymph Node Micrometastasis And Prognosis
169.	Anti-tumor Activity Of Fucoxanthin, An Active Ingredient Of Kelp Extract, Against Human NSCLC And Its Mechanism
170.	Detection And Identification Of Serum Biomarkers Of Non-small Cell Lung Cancer
171.	Research Of Health Technology Assessment For PET-CT In The Diagnosis Of Non-small Cell Lung Cancer
172.	The Efficacy Prediction Of Tyrosine Kinase Inhibitor For Treatment Of Advanced Non-small Cell Lung Cancer And The Related Basic Research
173.	The Changes Of CD4~+CD25~+ Regulatory T Cells Of Non Small-cell Lung Cancer Patients And The Effects Of CpG ODN
174.	Anti-Paclitaxel Resistance Effect Of Somatostatin Receptors Mediated Targeted Therapy On Non-small Cell Lung Cancer Cells And Its Possible Mechanisms
175.	Functional Imaging And Proteomics Techniques Predict Sensitivity To Chemoradiotherapy In Non-Small Cell Lung Cancer
176.	Combined Epidermal Growth Factor Receptor Targeting With The Tyrosine Kinase Inhibitor And The Monoclonal Antibody In No-Small Cell Lung Cancer
177.	Effects And Mechanisms Of Combined Treatment With Everolimus And Gefitinib On Non-small Cell Lung Cancer Cell Lines
178.	Clinical Relevance And Underlying Mechanism Of Altered Expression Of Proto-oncogene BCL11A In Non-small Cell Lung Cancer
179.	The Antitumor Activity Of A Novel Dual PI3Kα/mTOR Inhibitor PI-103 In Cancer Therapy
180.	Anticancer Activity And Mechanism Of Natural And Target-designed Small Molecule Compounds On Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to